FDA OKs implant for enlarged prostate symptoms

(AP)—Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.

The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back that presses against the urethra, causing difficulty urinating.

More than half of men in their sixties have some due to enlarged prostate, including frequent urination, weak stream and leaking. Current treatment options include drug therapy and surgery to remove part of the prostate. The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.

Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.

Related Stories

Listening to the urinary stream

date Apr 23, 2008

Benign prostate enlargement affects most of the elder men and often compresses the urethra resulting in voiding symptoms. Dutch researcher Tim Idzenga has found a way to measure the resistance of the urethra using sound: ...

Recommended for you

Racial differences in male breast cancer outcomes

date 21 hours ago

While black and white men under age 65 diagnosed with early-stage breast cancer received similar treatment, blacks had a 76% higher risk of death than whites, according to a new study. The study, published ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.